cdmo.directory
← Compare landing

Asimov vs FUJIFILM Biotechnologies

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAsimovFUJIFILM Biotechnologies
SummaryAsimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.
Services
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Viral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
Development capabilities
  • Analytical method development
  • Cell line development
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Stainless Steel
Locations
  • Headquarters, Boston, MA, USA
  • Headquarters, Cambridge, MA, USA
  • College Station, College Station, TX, USA
  • Holly Springs, Holly Springs, NC, USA
  • Research Triangle Park, Research Triangle Park, NC, USA
  • Thousand Oaks, Thousand Oaks, CA, USA
  • Billingham, Billingham, UK
  • Wilton, Wilton, UK
  • Hillerød, Hillerød, Denmark
  • Japan, Japan
  • US Facility, United States
  • United States, United States
  • Headquarters
  • Commercial-scale manufacturing, Hillerød, Denmark
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Asimov alternatives · FUJIFILM Biotechnologies alternatives

Markdown mirror: /compare/asimov/fujifilm-biotechnologies.md